For World Cancer Day, it seems the right time to highlight some of the stark data on expected future cancers around the globe. Regardless...

Over time, litigators dealing with cancer issues will need to become more attuned to asking plaintiffs and their doctors more questions...

The litigation industry is global. The latest example is the start of RoundUp/glyphosate litigation in Australia, as described in this...

The appeal is underway for Monsanto from the verdict in the DeWayne Johnson case. Numerous stories spin the papers. For those who prefer...

For persons facing cancer in the Chicago area, May 11, 2019 will bring a local opportunity to learn about the entire range of legal...

The $15 billion or so Quebec class action verdict in Canada against tobacco companies was upheld late on Friday in a 440 page opinion, in...

It’s world cancer day, a reminder of the biggest global terrorist and driver of much litigation. The chart is from: Bray F, Ferlay J,...

From AACR 2018 Cancer Report The chart and text are from the 2018 Cancer Progress Report from the American Association for Cancer...

More and more molecular data will arrive over the next few years; some of it will be very valuable for more deeply understanding when and...

Age of exposure to toxins is receiving increasing attention from researchers. Below, the abstract from an interesting study of arsenic...

Use of genomic testing continues to increase to seek to explain the reasons for and drivers of cancer. Some aspects of the newest broad...

It’s good to see more lawyers focused on genomics as related to causation in mass tort cases. A group from Goldberg Segalla just wrote...

Some scientific findings provide both opportunities and risks for litigants in mass tort cases. The point is highlighted by a new paper...

Caps on medical malpractice verdicts raise real issues of due process, right to trial and fundamental fairness. Therefore, it seems...

We continue to see increases in the the scale and pace of the development of molecular and genetic knowledge. A recent example arises...

Yesterday’s punitive damages verdict against J&J arrived after interesting questions from the jury to the court. One wonders how J&J will...

Therapy with CAR-T cells (artificially modified t-cells) is a “hot” idea these days in cancer therapy.  Last week, the Mesothelioma...

ToxicoGenomica is the doing business name for a collaboration between me and scientists at ArrayXpress and Innovative Science Solutions....

Jock McCulloch (and colleagues) wrote multiple books attacking companies that manufactured and/or sold asbestos-containing products in...